Current Barriers to the Implementation and Exploitation of Digital and MedTech Solutions in Europe

by GENESIS Biomed

6 years ago
digital solutions, MedTech, ITEMAS 2020, health

Projects working towards the development of digital and MedTech solutions are on its rise. However before starting to develop these new solutions, it is essential to understand the current landscape f...

We interview Sara Secall, Inveready’s Director of Investments in Life Sciences

by GENESIS Biomed

6 years ago
Life Sciences, Inveready, Sara Secall, drugs, diagnosis, Health, gene therapy

Sara Secall, a chemistry graduate with a master’s degree in environmental science and an MBA, is the current partner and director of investments in Life Sciences at Inveready, a Venture Capital (VC)...

FoodTech: new trends in food technology and health

by GENESIS Biomed

6 years ago
technology, food, FoodTech, health, Precision Nutrition, BeYou, Foodini, IrsiCaixa, Cook2Health, EIT Health, EIT Food, coaching

GENESIS Biomed is actively working in food innovation projects focused on improving human’s health

Dr. Scott Boyer joins Chemotargets as new CEO

by GENESIS Biomed

6 years ago
Dr. Scott Boyer, Chemotargets, Klaria, AstraZeneca, Pfizer, artificial intelligence, drugs, CLARITY, CREA Inversión

With the new incorporation, the company consolidates its transition from a software business to an AI-driven biotech

EIT Health Investors Network: a key opportunity for start-ups in search of funding

by GENESIS Biomed

6 years ago
Asebio Investor Day, start-ups, funds, EIT Health Investors

AseBio Investor Day’s round table on fundraising in Europe gathered EIT Health Investor Network’s main stakeholders

Aortyx gana el premio Alex Casta

by GENESIS Biomed

6 years ago
digital health, Aortyx, IQS Tech Factory, Àlex Casta, GENESIS Biomed, startup

Aortyx, apoyada en su origen por IQS Tech Factory, ha sido la startup más votada en la final de los Premis Àlex Casta como mejor pitch de la Bioregión. La startup fundada y dirigida por Jordi Ma...

Having a good understanding with your team is essential: they will make your company grow

by GENESIS Biomed

6 years ago
investors, company, Caixaimpulse, Catapult de EIT Health, Aortyx

At the end of last year Aortyx secured the biggest financing round of the sector (650K) without Venture Capitals or crowdfunding platforms. This start-up from Institut Químic de Sarrià’s (IQS) S

Marta Barrachina: 'I am confident that there will be advances in Alzheimer’s in the short term'

by GENESIS Biomed

6 years ago
diagnostic test, healthcare, ADmit Therapeutics, Alzheimer, Marta Barrachina

Despite the Covid-19 pandemic, 2020 has been a great year for ADmit Therapeutics, a spin-off from Bellvitge Biomedical Research Institute (IDIBELL, in Barcelona) born at the end of 2017 and leaded by ...

The great entrepreneurship moment of Madrid healthcare ecosystem

by GENESIS Biomed

6 years ago
entrepreneurship, healthcare, spin-off, ITEMAS, Corify Care, Telara Pharmaceuticals, POSITIVE

In the last 18 months 4 new hospital spin-off have been approved with the support of GENESIS Biomed

Joan Roca: 'As chefs we have a great responsibility'

by GENESIS Biomed

6 years ago
children’s obesity, Joan Roca, LiverScreen, nutrition, liver fibrosis, health education

The prominent chef Joan Roca, main chef at El Celler de Can Roca, is the ambassador of LiverScreen, a research program that aims to reduce mortality caused by liver diseases. It will analyse how an ea...

A sector in good shape despite the Covid-19 pandemic

by GENESIS Biomed

6 years ago
ITEMAS, private investment, healthcare, ASABYS Partners, Invivo Capital, ASEBIO, GENESIS Biomed, GENESIS Ventures

ITEMAS last webinar showed the optimism of healthcare investors

Covid-19: first-hand experiences from entrepreneurs

by GENESIS Biomed

6 years ago
telecommuting, entrepreneurs, covid-19, start-up, teletrabajo, Admit Therapeutics, Aortyx, Corify, Cornea, CreatSens, Oxolife

The SARS-CoV-2 pandemic that is hitting many countries has clearly affected the medical start-up and spin-off ecosystem. After talking to some of the companies we support we have seen that it has not ...